Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Richman

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|March 16, 2007
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109bJae-Kyu Jung, Benjamin R Johnson, Tracy Duong, et al.
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109bPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
Journal of Pharmacological and Toxicological Methods|July 24, 2007
Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonistsEster Carballo-Jane, Lynn S Gerckens, Silvi Luell, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2007
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109aPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2016
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 RatCarine M Boustany-Kari, Paul C Harrison, Hongxing Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agentsPeter I Dosa, Sonja Strah-Pleynet, Honnappa Jayakumar, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2010
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)P Douglas Boatman, Thomas O Schrader, Michelle Kasem, et al.
The Journal of Biological Chemistry|April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectorsJeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|March 16, 2007
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109bJae-Kyu Jung, Benjamin R Johnson, Tracy Duong, et al.
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109bPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
Journal of Pharmacological and Toxicological Methods|July 24, 2007
Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonistsEster Carballo-Jane, Lynn S Gerckens, Silvi Luell, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2007
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109aPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2016
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 RatCarine M Boustany-Kari, Paul C Harrison, Hongxing Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agentsPeter I Dosa, Sonja Strah-Pleynet, Honnappa Jayakumar, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2010
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)P Douglas Boatman, Thomas O Schrader, Michelle Kasem, et al.
The Journal of Biological Chemistry|April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectorsJeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Pageof 6